Towards host-directed therapies for tuberculosis
Copyright policy )SNSF| Integrating Genomic and Ecologic Approaches to Understand the Nature and Consequence of Genetic Diversity in Mycobacterium tuberculosis
Zumla, A.; Chakaya, J.; Hoelscher, M.; Ntoumi, F.; Rustomjee, R.; Vilaplana, C.; Yeboah-Manu, D.; +58 Authors
Zumla, A.; Chakaya, J.; Hoelscher, M.; Ntoumi, F.; Rustomjee, R.; Vilaplana, C.; Yeboah-Manu, D.; Rasolof, V.; Munderi, P.; Singh, N.; Aklillu, E.; Padayatchi, N.; Macete, E.; Kapata, N.; Mulenga, M.; Kibiki, G.; Mfinanga, S.; Nyirenda, T.; Maboko, L.; Garcia-Basteiro, A.; Rakotosamimanana, N.; Bates, M.; Mwaba, P.; Reither, K.; Gagneux, S.; Edwards, S.; Mfinanga, E.; Abdulla, S.; Cardona, P. J.; Russell, J. B.; Gant, V.; Noursadeghi, M.; Elkington, P.; Bonnet, M.; Menendez, C.; Dieye, T. N.; Diarra, B.; Maiga, A.; Aseffa, A.; Parida, S.; Wejse, C.; Petersen, E.; Kaleebu, P.; Oliver, M.; Craig, G.; Corrah, T.; Tientcheu, L.; Antonio, M.; Rao, M.; McHugh, T. D.; Sheikh, A.; Ippolito, G.; Ramjee, G.; Kaufmann, S. H.; Churchyard, G.; Steyn, A.; Grobusch, M.; Sanne, I.; Martinson, N.; Madansein, R.; Wilkinson, R. J.; Mayosi, B.; Schito, M.; Wallis, R. S.; Maeurer, M.;
Towards host-directed therapies for tuberculosis
The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies.
United Kingdom, Switzerland, Netherlands, United Kingdom
- University College London United Kingdom
- Institut Pasteur France
- University of Cape Town South Africa
- German Center for Infection Research Germany
- University of KwaZulu-Natal South Africa
Antitubercular Agents, Mycobacterium tuberculosis, References, 540, Author information, Change history, Supplementary information, Drug Design, 616, Humans, Tuberculosis, Drug Therapy, Combination, Molecular Targeted Therapy, RC
Antitubercular Agents, Mycobacterium tuberculosis, References, 540, Author information, Change history, Supplementary information, Drug Design, 616, Humans, Tuberculosis, Drug Therapy, Combination, Molecular Targeted Therapy, RC
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).120 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
selected citations
Citations provided by BIP!
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
Citations provided by BIP!popularityPopularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
Popularity provided by BIP! 120
Top 1%
Top 10%
Top 1%
Green
hybrid
